Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Background: Heart failure as an important issue in global public health, has brought a heavy economic burden. Traditional Chinese medicine injections (TCMIs) have significant effects on heart failure with reduced ejection fraction (HFrEF). However, it is difficult for clinicians to identify the diff...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shanshan Lin, Qingyang Shi, Zhao Ge, Yangxi Liu, Yawen Cao, Ying Yang, Zhiqiang Zhao, Yingfei Bi, Yazhu Hou, Shuai Wang, Xianliang Wang, Jingyuan Mao
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/3895c6997dd94ea085abb5b1c8a047f8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3895c6997dd94ea085abb5b1c8a047f8
record_format dspace
spelling oai:doaj.org-article:3895c6997dd94ea085abb5b1c8a047f82021-12-01T18:54:15ZEfficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials1663-981210.3389/fphar.2021.659707https://doaj.org/article/3895c6997dd94ea085abb5b1c8a047f82021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.659707/fullhttps://doaj.org/toc/1663-9812Background: Heart failure as an important issue in global public health, has brought a heavy economic burden. Traditional Chinese medicine injections (TCMIs) have significant effects on heart failure with reduced ejection fraction (HFrEF). However, it is difficult for clinicians to identify the differences in clinical efficacy and safety of various TCMIs. The purpose of this study is to compare the efficacy and safety of various TCMIs for treating HFrEF by conducting a Bayesian network meta-analysis (NMA) and to further provide references for clinical decision-making.Methods: The clinical randomized controlled trials of TCMIs for treating HFrEF were searched in seven database from inception to August 3rd, 2021. The Cochrane collaboration’s tool was used to assess the risk of bias. NMA was performed in a Bayesian hierarchical framework. The surface under the cumulative ranking curve (SUCRA), the multi-dimensional efficacy analysis, the comparison-adjusted funnel plot, and the node-splitting analysis were conducted using R software.Results: A total of 107 eligible RCTs involving 9,073 HFrEF patients and 6 TCMIs were included. TCMIs include Huangqi injection (HQ) also called Astragalus injection, Shenfu injection (SF), Shengmai injection (SGM), Shenmai injection (SM), Xinmailong injection (XML), and Yiqifumai lyophilized injection (YQFM). The results of NMA and SUCRA showed that with conventional treatment (CT) as a common control, in terms of clinical efficacy, CT + XML was most effective in New York Heart Association cardiac functional classification efficiency, brain natriuretic peptide, and N-terminal pro-brain natriuretic peptide; the CT + SM was most effective in 6-min walking test, left ventricular end-diastolic diameter, left ventricular end-systolic diameter and cardiac output; the CT + YQFM was most effective in left ventricular ejection fraction; the CT + HQ was most effective in stroke volume; the CT + SF was most effective in Minnesota Living with Heart Failure Questionnaire. In terms of safety, there was no significant difference between CT + TCMIs and CT.Conclusion: This Bayesian network meta-analysis results show that the combination of qualified TCMIs and CT is more effective for HFrEF patients than CT alone, and CT + XML and CT + SM may be one of the potential optimal treatments. Also, the safety of these TCMIs needs to be further observed. However, due to some limitations, the conclusions need to be verified by more large-sample, double-blind, multi-center RCTs.Shanshan LinShanshan LinQingyang ShiZhao GeZhao GeYangxi LiuYangxi LiuYawen CaoYawen CaoYing YangZhiqiang ZhaoYingfei BiYazhu HouShuai WangXianliang WangJingyuan MaoFrontiers Media S.A.articletraditional chinese medicinetraditional chinese medicine injectionheart failurerandomized controlled trialnetwork meta-analysisbayesian modelTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic traditional chinese medicine
traditional chinese medicine injection
heart failure
randomized controlled trial
network meta-analysis
bayesian model
Therapeutics. Pharmacology
RM1-950
spellingShingle traditional chinese medicine
traditional chinese medicine injection
heart failure
randomized controlled trial
network meta-analysis
bayesian model
Therapeutics. Pharmacology
RM1-950
Shanshan Lin
Shanshan Lin
Qingyang Shi
Zhao Ge
Zhao Ge
Yangxi Liu
Yangxi Liu
Yawen Cao
Yawen Cao
Ying Yang
Zhiqiang Zhao
Yingfei Bi
Yazhu Hou
Shuai Wang
Xianliang Wang
Jingyuan Mao
Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
description Background: Heart failure as an important issue in global public health, has brought a heavy economic burden. Traditional Chinese medicine injections (TCMIs) have significant effects on heart failure with reduced ejection fraction (HFrEF). However, it is difficult for clinicians to identify the differences in clinical efficacy and safety of various TCMIs. The purpose of this study is to compare the efficacy and safety of various TCMIs for treating HFrEF by conducting a Bayesian network meta-analysis (NMA) and to further provide references for clinical decision-making.Methods: The clinical randomized controlled trials of TCMIs for treating HFrEF were searched in seven database from inception to August 3rd, 2021. The Cochrane collaboration’s tool was used to assess the risk of bias. NMA was performed in a Bayesian hierarchical framework. The surface under the cumulative ranking curve (SUCRA), the multi-dimensional efficacy analysis, the comparison-adjusted funnel plot, and the node-splitting analysis were conducted using R software.Results: A total of 107 eligible RCTs involving 9,073 HFrEF patients and 6 TCMIs were included. TCMIs include Huangqi injection (HQ) also called Astragalus injection, Shenfu injection (SF), Shengmai injection (SGM), Shenmai injection (SM), Xinmailong injection (XML), and Yiqifumai lyophilized injection (YQFM). The results of NMA and SUCRA showed that with conventional treatment (CT) as a common control, in terms of clinical efficacy, CT + XML was most effective in New York Heart Association cardiac functional classification efficiency, brain natriuretic peptide, and N-terminal pro-brain natriuretic peptide; the CT + SM was most effective in 6-min walking test, left ventricular end-diastolic diameter, left ventricular end-systolic diameter and cardiac output; the CT + YQFM was most effective in left ventricular ejection fraction; the CT + HQ was most effective in stroke volume; the CT + SF was most effective in Minnesota Living with Heart Failure Questionnaire. In terms of safety, there was no significant difference between CT + TCMIs and CT.Conclusion: This Bayesian network meta-analysis results show that the combination of qualified TCMIs and CT is more effective for HFrEF patients than CT alone, and CT + XML and CT + SM may be one of the potential optimal treatments. Also, the safety of these TCMIs needs to be further observed. However, due to some limitations, the conclusions need to be verified by more large-sample, double-blind, multi-center RCTs.
format article
author Shanshan Lin
Shanshan Lin
Qingyang Shi
Zhao Ge
Zhao Ge
Yangxi Liu
Yangxi Liu
Yawen Cao
Yawen Cao
Ying Yang
Zhiqiang Zhao
Yingfei Bi
Yazhu Hou
Shuai Wang
Xianliang Wang
Jingyuan Mao
author_facet Shanshan Lin
Shanshan Lin
Qingyang Shi
Zhao Ge
Zhao Ge
Yangxi Liu
Yangxi Liu
Yawen Cao
Yawen Cao
Ying Yang
Zhiqiang Zhao
Yingfei Bi
Yazhu Hou
Shuai Wang
Xianliang Wang
Jingyuan Mao
author_sort Shanshan Lin
title Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
title_short Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
title_full Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
title_fullStr Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
title_full_unstemmed Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
title_sort efficacy and safety of traditional chinese medicine injections for heart failure with reduced ejection fraction: a bayesian network meta-analysis of randomized controlled trials
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/3895c6997dd94ea085abb5b1c8a047f8
work_keys_str_mv AT shanshanlin efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT shanshanlin efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT qingyangshi efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT zhaoge efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT zhaoge efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT yangxiliu efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT yangxiliu efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT yawencao efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT yawencao efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT yingyang efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT zhiqiangzhao efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT yingfeibi efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT yazhuhou efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT shuaiwang efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT xianliangwang efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT jingyuanmao efficacyandsafetyoftraditionalchinesemedicineinjectionsforheartfailurewithreducedejectionfractionabayesiannetworkmetaanalysisofrandomizedcontrolledtrials
_version_ 1718404623559032832